[Parachute Implantation in Severe Ischemic Cardiomyopathy].

Congestive heart failure related to myocardial infarction is characterized by left-ventricular remodeling and moreover it is associated with significant morbidity and mortality with currently limited therapeutic options. The catheter-based left ventricular partitioning device (ParachuteTM, CardioKinetix, Inc., Menlo Park, CA) is a novel therapeutic option available for patients with severe systolic dysfunction following antero-apical myocardial infarction with regional wall motion abnormalities. Preliminary clinical data indicate in addition to the safety the improvement in left ventricular hemodynamics, functional capacity and quality of life.